Related references
Note: Only part of the references are listed.Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John Ma et al.
HAEMATOLOGICA (2022)
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity
Ewa Cendrowicz et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Novel insights into the function ofCD24: A driving force in cancer
Peter Altevogt et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Nan Xiao et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)
2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management
Sandra Susanibar-Adaniya et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
Wookyeom Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
Robert W. Lentz et al.
MOLECULAR CANCER THERAPEUTICS (2021)
The Role of Macrophages in Cancer Development and Therapy
Ewa Cendrowicz et al.
CANCERS (2021)
Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies
Shiran Shapira et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance
Li-Yan Qiao et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2021)
Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
Shan-Shan Yin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Unveiling Molecular Recognition of Sialoglycans by Human Siglec-10
Rosa Ester Forgione et al.
ISCIENCE (2020)
Emerging therapies in mantle cell lymphoma
Walter Hanel et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir Sikic et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management
Preetesh Jain et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Macrophage Polarization in Physiological and Pathological Pregnancy
Yongli Yao et al.
FRONTIERS IN IMMUNOLOGY (2019)
Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
Peng Zhang et al.
FRONTIERS IN GENETICS (2019)
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
Renee Bouwstra et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Overview of CD24 as a new molecular marker in ovarian cancer
Vahideh Tarhriz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Anticancer effects of anti-CD47 immunotherapy in vivo
Kristina Iribarren et al.
ONCOIMMUNOLOGY (2019)
CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer
Ji-Lin Wang et al.
CLINICAL LABORATORY (2018)
CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises
Bing Tong et al.
FUTURE ONCOLOGY (2018)
Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity
Hui-Ming Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Fane F. K. Mensah et al.
FRONTIERS IN IMMUNOLOGY (2018)
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
Amira A. Barkal et al.
NATURE IMMUNOLOGY (2018)
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
Wenzhe Li et al.
SCIENTIFIC REPORTS (2017)
CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse Receptors
D. Craig Ayre et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors
Safia Salaria et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
Mi Jeong Kwon et al.
PLOS ONE (2015)
Molecular and epigenetic basis of macrophage polarized activation
Chiara Porta et al.
SEMINARS IN IMMUNOLOGY (2015)
Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3K
Nikitha K. Pallegar et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Intracellular Signaling Transduction Pathways Triggered by a Well-Known Anti-GHR Monoclonal Antibody, Mab263, in Vitro and in Vivo
Hainan Lan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CD24 controls Src/STAT3 activity in human tumors
Niko P. Bretz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated
Jonathan B. Overdevest et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Direct Measurements on CD24-Mediated Rolling of Human Breast Cancer MCF-7 Cells on E-Selectin
Ja Hye Myung et al.
ANALYTICAL CHEMISTRY (2011)
Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis
Glen Kristiansen et al.
LABORATORY INVESTIGATION (2010)
Lipid Rafts As a Membrane-Organizing Principle
Daniel Lingwood et al.
SCIENCE (2010)
CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
Guo-Yun Chen et al.
SCIENCE (2009)
Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis
Steffen Blenk et al.
BMC CANCER (2008)
L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis
D. Finas et al.
HUMAN REPRODUCTION (2008)
Molecular diagnosis of Burkitt's lymphoma
Sandeep S. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer
SC Smith et al.
CANCER RESEARCH (2006)
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
AM Glas et al.
BLOOD (2005)
Expression profile and prognostic significance of CD24, p53 and p21 in non-Hodgkin-lymphomas
P Went et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2004)
Peritoneal macrophages express both P-selectin and PSGL-1
B Tchernychev et al.
JOURNAL OF CELL BIOLOGY (2003)
CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system
T Suzuki et al.
JOURNAL OF IMMUNOLOGY (2001)
Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts
VA Fadok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
